Ted Mann, a Bloomberg News Money and Influence reporter, discusses Elon Musk's controversial strategies that are ruffling feathers in the U.S. Treasury. Kevin Jacobs, Hilton's CFO, highlights the company’s record growth and optimistic outlook for the travel sector. Geoff Meacham, Citibank's Global Head of Healthcare, provides insights into pharmaceutical earnings, particularly from Eli Lilly and Pfizer, amid rising industry trends. The conversation sheds light on the economic landscape shaped by these developments.
